The Global Glutathione Market is valued at approximately USD 301.3 million in 2025 and is projected to grow at a CAGR of 7.83% to reach approximately USD 473.6 million by 2031 (forecast period 2026-2031, base year 2025). The market is segmented by type into Reduced Glutathione (GSH), Oxidized Glutathione (GSSG); and by application into Pharmaceuticals & API, Nutraceuticals / Health Products, Cosmetics & Personal Care, Food & Beverage, Other (Reagent, Diagnostic). Regional value shares in 2025: Asia Pacific 52.0%, Europe 20.0%, North America 19.0%, Latin America 5.0%, Middle East & Africa 4.0%.
The report provides market sizing in value across type, application, regional and country segments through 2031, a competitive landscape with company-level profiles covering financial performance, business strategy and SWOT analysis, and strategic implications for each profiled company.
The report profiles 6 companies including Kyowa Hakko Bio Co. Ltd., KOHJIN Life Sciences Co. Ltd., Shandong Jincheng Pharmaceutical Group, Merck KGaA, Kaneka Corporation, Gnosis by Lesaffre, and is intended for corporate strategy, investment, M&A and procurement teams, with Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook.
The report provides market sizing in value across type, application, regional and country segments through 2031, a competitive landscape with company-level profiles covering financial performance, business strategy and SWOT analysis, and strategic implications for each profiled company.
The report profiles 6 companies including Kyowa Hakko Bio Co. Ltd., KOHJIN Life Sciences Co. Ltd., Shandong Jincheng Pharmaceutical Group, Merck KGaA, Kaneka Corporation, Gnosis by Lesaffre, and is intended for corporate strategy, investment, M&A and procurement teams, with Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook.
Table of Contents
1. Executive Summary2. Industry Overview & Forecast
3. Market Segmentation by Type
4. Market Segmentation by Application
5. Regional Market Forecast
6. Country-Level Market Forecast
7. Growth Drivers & Inhibitors
8. Key Company Profiles (Kyowa Hakko Bio Co. Ltd., KOHJIN Life Sciences Co. Ltd., Shandong Jincheng Pharmaceutical Group, Merck KGaA, Kaneka Corporation, Gnosis by Lesaffre)
9. Competitive Landscape
10. Porter's Five Forces Analysis
11. PESTLE Analysis
12. SWOT Analysis
13. Future Trends & Outlook
Companies Mentioned
- Kyowa Hakko Bio Co. Ltd.
- KOHJIN Life Sciences Co. Ltd.
- Shandong Jincheng Pharmaceutical Group
- Merck KGaA
- Kaneka Corporation
- Gnosis by Lesaffre
